Focused radiosurgery extends survival for small cell lung cancer patients with brain metastases

Original source summary

Patients with small cell lung cancer (SCLC) that had spread to the brain lived a median of 17 months after focused stereotactic radiosurgery, compared with nine months after an advanced form of whole brain radiation therapy, an unexpected secondary finding from the first randomized phase 3 trial to compare the treatment approaches in this population.

Verbatim from News-Medical's own feed — "Focused radiosurgery extends survival for small cell lung cancer patients with brain metastases"